Searching News Database: Transdermal
HSMN NewsFeed - 5 May 2021
Isosceles Pharmaceuticals, Inc. Appoints William D. Humphries as its Chief Executive Officer
Isosceles Pharmaceuticals, Inc. Appoints William D. Humphries as its Chief Executive Officer
HSMN NewsFeed - 26 Feb 2020
Evofem Biosciences Appoints Former FDA Division Director Lisa Rarick, M.D., to its Board of Directors
Evofem Biosciences Appoints Former FDA Division Director Lisa Rarick, M.D., to its Board of Directors
HSMN NewsFeed - 10 Feb 2020
Enteris BioPharma Appoints Gary A. Shangold, MD, as Chief Medical Officer
Enteris BioPharma Appoints Gary A. Shangold, MD, as Chief Medical Officer
HSMN NewsFeed - 9 Jul 2018
Mylan Adds to Central Nervous System Portfolio With Launch of Generic Exelon(R) Patch
Mylan Adds to Central Nervous System Portfolio With Launch of Generic Exelon(R) Patch
HSMN NewsFeed - 28 May 2018
Luye Pharma Acquires AstraZeneca's Signature Products Seroquel and Seroquel XR
Luye Pharma Acquires AstraZeneca's Signature Products Seroquel and Seroquel XR
HSMN NewsFeed - 25 Apr 2018
Dermtreat Appoints Nishan de Silva, M.D., as CEO; Establishes North American Headquarters in San Diego
Dermtreat Appoints Nishan de Silva, M.D., as CEO; Establishes North American Headquarters in San Diego
HSMN NewsFeed - 29 Jan 2018
Bioness Receives Health Canada Approval for StimRouter Neuromodulation System
Bioness Receives Health Canada Approval for StimRouter Neuromodulation System
HSMN NewsFeed - 29 Dec 2017
Mylan Adds to U.S. Women's Healthcare Portfolio With FDA Approval of First Generic for Estrace(R) Cream
Mylan Adds to U.S. Women's Healthcare Portfolio With FDA Approval of First Generic for Estrace(R) Cream
HSMN NewsFeed - 7 Dec 2017
Bioness StimRouter(R) Neuromodulation System Eligible for Increased Medicare Reimbursements
Bioness StimRouter(R) Neuromodulation System Eligible for Increased Medicare Reimbursements
HSMN NewsFeed - 20 Sep 2017
DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development
DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development
HSMN NewsFeed - 1 Feb 2016
Bioness Announces the Publication of StimRouter(TM) Neuromodulation System Clinical Trial
Bioness Announces the Publication of StimRouter(TM) Neuromodulation System Clinical Trial
HSMN NewsFeed - 13 Oct 2015
GTx Receives FDA Clearance to Initiate Clinical Trial in Stress Urinary Incontinence
GTx Receives FDA Clearance to Initiate Clinical Trial in Stress Urinary Incontinence
HSMN NewsFeed - 16 Sep 2015
Bioness Announces First Commercial Procedure of StimRouter(TM) Neuromodulation System
Bioness Announces First Commercial Procedure of StimRouter(TM) Neuromodulation System
HSMN NewsFeed - 18 Aug 2015
Radius Health Announced That it Has Appointed Catherine Friedman to the Board of Directors
Radius Health Announced That it Has Appointed Catherine Friedman to the Board of Directors
HSMN NewsFeed - 3 Jun 2015
Alliqua BioMedical, Inc. Appoints Nino Pionati as Chief Strategy and Marketing Officer
Alliqua BioMedical, Inc. Appoints Nino Pionati as Chief Strategy and Marketing Officer
HSMN NewsFeed - 26 Mar 2015
Bioness Initiates Pilot Study of StimRouter(TM) Neuromodulation System for Overactive Bladder (OAB)
Bioness Initiates Pilot Study of StimRouter(TM) Neuromodulation System for Overactive Bladder (OAB)
HSMN NewsFeed - 13 Nov 2014
Nuvo Research(R) reacquires Pennsaid(R) 2% rights to South America, Central America, South Africa and Israel
Nuvo Research(R) reacquires Pennsaid(R) 2% rights to South America, Central America, South Africa and Israel
HSMN NewsFeed - 29 Sep 2014
Lumara Health(TM) to be Acquired in Two Separate Transactions for up to $1.107 Billion
Lumara Health(TM) to be Acquired in Two Separate Transactions for up to $1.107 Billion
HSMN NewsFeed - 18 Sep 2014
Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development
Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development
HSMN NewsFeed - 5 Aug 2014
Aeterna Zentaris and ASCEND Therapeutics Sign Co-Promotion Agreement for U.S. Market
Aeterna Zentaris and ASCEND Therapeutics Sign Co-Promotion Agreement for U.S. Market
HSMN NewsFeed - 10 Feb 2014
Alliqua Appoints Janice M. Smiell, M.D. as its First Chief Medical Officer
Alliqua Appoints Janice M. Smiell, M.D. as its First Chief Medical Officer
HSMN NewsFeed - 7 Jan 2014
Impax and DURECT Sign a $63 Million Agreement to Develop and Commercialize DURECT’s ELADUR(R) Pain Patch
Impax and DURECT Sign a $63 Million Agreement to Develop and Commercialize DURECT’s ELADUR(R) Pain Patch
HSMN NewsFeed - 12 Nov 2013
Alliqua Receives $1M from Crossover Healthcare Fund, LLC to Pursue Key Wound Care Initiatives
Alliqua Receives $1M from Crossover Healthcare Fund, LLC to Pursue Key Wound Care Initiatives
HSMN NewsFeed - 18 Jul 2013
Alliqua's SilverSeal Dressing Shown to Improve Surgical Wound Outcomes in Clinical Study
Alliqua's SilverSeal Dressing Shown to Improve Surgical Wound Outcomes in Clinical Study
HSMN NewsFeed - 11 Feb 2013
Alliqua Demonstrates Wound Healing Benefit of SilverSeal(R) Dressing on Foot and Ankle Post-Surgical Wounds
Alliqua Demonstrates Wound Healing Benefit of SilverSeal(R) Dressing on Foot and Ankle Post-Surgical Wounds
HSMN NewsFeed - 25 Jan 2013
FDA Approves OXYTROL(R) FOR WOMEN, the First Over-the-Counter Treatment for Overactive Bladder in Women
FDA Approves OXYTROL(R) FOR WOMEN, the First Over-the-Counter Treatment for Overactive Bladder in Women
HSMN NewsFeed - 19 Nov 2012
Echo Therapeutics Hires Daniel Sunday as Vice President of Manufacturing and Global Supply Chain
Echo Therapeutics Hires Daniel Sunday as Vice President of Manufacturing and Global Supply Chain
HSMN NewsFeed - 4 Oct 2012
BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Merger Agreement
BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Merger Agreement
HSMN NewsFeed - 9 Aug 2012
Echo Therapeutics Announces $20 Million Financing with Platinum-Montaur Life Sciences
Echo Therapeutics Announces $20 Million Financing with Platinum-Montaur Life Sciences
HSMN NewsFeed - 24 Jul 2012
Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing
Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing
HSMN NewsFeed - 16 Jul 2012
UCB Launches Neupro(R) in the U.S. to Treat Parkinson’s Disease and Restless Legs Syndrome
UCB Launches Neupro(R) in the U.S. to Treat Parkinson’s Disease and Restless Legs Syndrome
HSMN NewsFeed - 2 Jul 2012
Antares Pharma Appoints Jonathan S. Jaffe MD Vice President of Clinical Development
Antares Pharma Appoints Jonathan S. Jaffe MD Vice President of Clinical Development
HSMN NewsFeed - 10 May 2012
Incline Therapeutics Announces Appointment of John Tucker as Chief Commercial Officer
Incline Therapeutics Announces Appointment of John Tucker as Chief Commercial Officer
HSMN NewsFeed - 3 Apr 2012
Neupro(R) Approved by U.S. FDA for Parkinson’s Disease and Restless Legs Syndrome
Neupro(R) Approved by U.S. FDA for Parkinson’s Disease and Restless Legs Syndrome
HSMN NewsFeed - 16 Dec 2011
Radius Closes $21.4 Million Third and Final Equity Tranche of Previously Announced Financing
Radius Closes $21.4 Million Third and Final Equity Tranche of Previously Announced Financing
HSMN NewsFeed - 8 Dec 2011
Antares' Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder
Antares' Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder
HSMN NewsFeed - 21 Nov 2011
Mylan Announces Settlement Agreement for its First-to-File Generic Version of Vivelle-Dot(R)
Mylan Announces Settlement Agreement for its First-to-File Generic Version of Vivelle-Dot(R)
HSMN NewsFeed - 14 Oct 2011
EMKinetics Announces Start of Pivotal Trial for the TranStim(TM) Transdermal Neuromodulation System
EMKinetics Announces Start of Pivotal Trial for the TranStim(TM) Transdermal Neuromodulation System
HSMN NewsFeed - 26 Sep 2011
Easton Pharmaceuticals Strengthens Sales Capabilities With Key Management Team Addition
Easton Pharmaceuticals Strengthens Sales Capabilities With Key Management Team Addition
HSMN NewsFeed - 4 Aug 2011
Antares Pharma Announces Positive Study Results with VIBEX(TM) MTX in Rheumatoid Arthritis Patients
Antares Pharma Announces Positive Study Results with VIBEX(TM) MTX in Rheumatoid Arthritis Patients
HSMN NewsFeed - 11 Jul 2011
Watson and Antares Announce Exclusive License Agreement for Antares' Oxybutynin Gel Product (Anturol(R))
Watson and Antares Announce Exclusive License Agreement for Antares' Oxybutynin Gel Product (Anturol(R))
HSMN NewsFeed - 14 Jun 2011
Easton Pharmaceuticals Announces The Appointment of John Easton as Interim Chief Executive Officer
Easton Pharmaceuticals Announces The Appointment of John Easton as Interim Chief Executive Officer
HSMN NewsFeed - 25 Apr 2011
FDA Issues Complete Response Letter for Aricept(R) Patch (donepezil transdermal system)
FDA Issues Complete Response Letter for Aricept(R) Patch (donepezil transdermal system)
HSMN NewsFeed - 14 Feb 2011
BioSante Pharmaceuticals Reports Positive LibiGel(R) Safety Data in Phase III Program
BioSante Pharmaceuticals Reports Positive LibiGel(R) Safety Data in Phase III Program
HSMN NewsFeed - 30 Aug 2010
Easton Pharmaceuticals Inc. Announces Experienced CFO Appointment to Management Team
Easton Pharmaceuticals Inc. Announces Experienced CFO Appointment to Management Team
HSMN NewsFeed - 23 Jul 2010
Emisphere Provides an Update on Osteoarthritis Phase III Study With Oral Calcitonin
Emisphere Provides an Update on Osteoarthritis Phase III Study With Oral Calcitonin
HSMN NewsFeed - 23 Apr 2010
UCB Receives Complete Response Letter from U.S. FDA Regarding Neupro(R) (Rotigotine)
UCB Receives Complete Response Letter from U.S. FDA Regarding Neupro(R) (Rotigotine)
HSMN NewsFeed - 23 Apr 2010
InteKrin Therapeutics Appoints Roman Skowronski, MD, PhD as Vice President of Clinical Development
InteKrin Therapeutics Appoints Roman Skowronski, MD, PhD as Vice President of Clinical Development
HSMN NewsFeed - 3 Mar 2010
Solasia Pharma and Kyowa Hakko Kirin Enter Into a License Agreement for SP-01 (Sancuso) in Asia
Solasia Pharma and Kyowa Hakko Kirin Enter Into a License Agreement for SP-01 (Sancuso) in Asia
HSMN NewsFeed - 9 Feb 2010
BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs
BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs
HSMN NewsFeed - 13 Oct 2009
Transdel Pharmaceuticals Appoints Dr. Joachim P.H. Schupp as Chief Medical Officer
Transdel Pharmaceuticals Appoints Dr. Joachim P.H. Schupp as Chief Medical Officer
HSMN NewsFeed - 18 Aug 2009
Par Pharmaceutical & Aveva Drug Delivery Systems Receive Final Approval to Market Generic Catapres TTS(R)
Par Pharmaceutical & Aveva Drug Delivery Systems Receive Final Approval to Market Generic Catapres TTS(R)
HSMN NewsFeed - 8 Jul 2009
Antares Pharma Promotes Robert F. Apple, Dr. Kaushik Dave and Dr. Peter Sadowski
Antares Pharma Promotes Robert F. Apple, Dr. Kaushik Dave and Dr. Peter Sadowski
HSMN NewsFeed - 30 Jun 2009
BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement
BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement
HSMN NewsFeed - 15 Jun 2009
DJO Incorporated Announces Sale of Empi Therapy Solutions Catalog Business to Patterson Medical
DJO Incorporated Announces Sale of Empi Therapy Solutions Catalog Business to Patterson Medical
HSMN NewsFeed - 29 May 2009
UCB receives CHMP positive opinion on bringing Neupro(R) back to all patients in Europe
UCB receives CHMP positive opinion on bringing Neupro(R) back to all patients in Europe
HSMN NewsFeed - 19 May 2009
Emisphere Technologies Appoints Franklin M. Berger to Its Board of Directors
Emisphere Technologies Appoints Franklin M. Berger to Its Board of Directors
HSMN NewsFeed - 16 Mar 2009
Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
HSMN NewsFeed - 27 Feb 2009
Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT
Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT
HSMN NewsFeed - 27 Jan 2009
Watson's GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder
Watson's GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder
HSMN NewsFeed - 31 Dec 2008
PriCara(R) Recalls 50 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches
PriCara(R) Recalls 50 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches
HSMN NewsFeed - 13 Oct 2008
Antares Pharma Appoints Paul K. Wotton, Ph.D., as President and Chief Executive Officer
Antares Pharma Appoints Paul K. Wotton, Ph.D., as President and Chief Executive Officer
HSMN NewsFeed - 29 Sep 2008
Noven Names Peter Amanatides as Vice President - Quality Assurance & Quality Control
Noven Names Peter Amanatides as Vice President - Quality Assurance & Quality Control
HSMN NewsFeed - 23 Sep 2008
Vyteris Announces Growth Initiative Through Expanded Business Development Team
Vyteris Announces Growth Initiative Through Expanded Business Development Team
HSMN NewsFeed - 8 Sep 2008
Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO
Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO
HSMN NewsFeed - 30 Jul 2008
Banner Pharmacaps Receives FDA Approval for Valproic Acid Delayed Release Softgel Capsules
Banner Pharmacaps Receives FDA Approval for Valproic Acid Delayed Release Softgel Capsules
HSMN NewsFeed - 14 Jul 2008
Noven Names Joel Lippman, M.D. as Vice President - Clinical Development & Chief Medical Officer
Noven Names Joel Lippman, M.D. as Vice President - Clinical Development & Chief Medical Officer
HSMN NewsFeed - 8 Jul 2008
Agile Therapeutics Appoints Senior Executive Jeffrey Frick as Chief Business Officer
Agile Therapeutics Appoints Senior Executive Jeffrey Frick as Chief Business Officer
HSMN NewsFeed - 7 Jul 2008
Antares Pharma Appoints Paul Wotton, Ph.D. as President and Chief Operating Officer
Antares Pharma Appoints Paul Wotton, Ph.D. as President and Chief Operating Officer
HSMN NewsFeed - 12 Jun 2008
Lilly and TransPharma Medical Announce Licensing and Development Agreement
Lilly and TransPharma Medical Announce Licensing and Development Agreement
HSMN NewsFeed - 29 Apr 2008
Noven Appoints Peter C. Brandt as President, Chief Executive Officer & Director
Noven Appoints Peter C. Brandt as President, Chief Executive Officer & Director
HSMN NewsFeed - 24 Apr 2008
Transdel Pharmaceuticals Appoints Chief Medical Officer and Chief Operating Officer
Transdel Pharmaceuticals Appoints Chief Medical Officer and Chief Operating Officer
HSMN NewsFeed - 16 Apr 2008
Schering-Plough Announces Imperfect Contraceptive Use Impacts Women's Emotional Well-Being
Schering-Plough Announces Imperfect Contraceptive Use Impacts Women's Emotional Well-Being
HSMN NewsFeed - 15 Apr 2008
BioSante Pharmaceuticals Appoints Michael C. Snabes, M.D., PhD, Vice President, Clinical Development
BioSante Pharmaceuticals Appoints Michael C. Snabes, M.D., PhD, Vice President, Clinical Development
HSMN NewsFeed - 7 Apr 2008
Endo Pharmaceuticals Provides Updates on FROVA(R) and CHRONOGESIC(R) Clinical Development Programs
Endo Pharmaceuticals Provides Updates on FROVA(R) and CHRONOGESIC(R) Clinical Development Programs
HSMN NewsFeed - 20 Mar 2008
UCB advises US-physicians to down-titrate patients on Neupro(R) in view of out-of-stock situation in the US
UCB advises US-physicians to down-titrate patients on Neupro(R) in view of out-of-stock situation in the US
HSMN NewsFeed - 29 Jan 2008
BioSante Pharmaceuticals Announces FDA Special Protocol Assessment (SPA) for LibiGel(R) in FSD
BioSante Pharmaceuticals Announces FDA Special Protocol Assessment (SPA) for LibiGel(R) in FSD
HSMN NewsFeed - 22 Jan 2008
RxElite Appoints Rick Schindewolf Vice President for Business Development
RxElite Appoints Rick Schindewolf Vice President for Business Development
HSMN NewsFeed - 16 Jan 2008
Recordati Licenses Kentera(R) From Watson Pharmaceuticals Inc. (U.S.A.) for Europe
Recordati Licenses Kentera(R) From Watson Pharmaceuticals Inc. (U.S.A.) for Europe
HSMN NewsFeed - 7 Jan 2008
Antares Pharma Develops Novel Pen Injector under New Agreement with Teva Pharmaceuticals
Antares Pharma Develops Novel Pen Injector under New Agreement with Teva Pharmaceuticals
HSMN NewsFeed - 3 Jan 2008
Akela Pharma licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica NV for Canada
Akela Pharma licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica NV for Canada
HSMN NewsFeed - 26 Dec 2007
Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed Release Capsules
Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed Release Capsules
HSMN NewsFeed - 13 Dec 2007
Neupro(R) Filed with the FDA for the Treatment of Advanced-Stage Parkinson's Disease
Neupro(R) Filed with the FDA for the Treatment of Advanced-Stage Parkinson's Disease
HSMN NewsFeed - 27 Nov 2007
Clarus Therapeutics Announces Completion of $8 Million Series C Financing Round
Clarus Therapeutics Announces Completion of $8 Million Series C Financing Round
HSMN NewsFeed - 6 Nov 2007
Transdel Pharmaceuticals Appoints Mr. Anthony S. Thornley to Its Board of Directors
Transdel Pharmaceuticals Appoints Mr. Anthony S. Thornley to Its Board of Directors
HSMN NewsFeed - 1 Nov 2007
Valeritas Announces Brand Name V-Go(TM) for Disposable Insulin Delivery Device
Valeritas Announces Brand Name V-Go(TM) for Disposable Insulin Delivery Device
HSMN NewsFeed - 30 Oct 2007
New Therapies Emerging to Challenge Pain Management for Transdermal Patch Growth
New Therapies Emerging to Challenge Pain Management for Transdermal Patch Growth
HSMN NewsFeed - 24 Oct 2007
Emisphere Technologies, Inc. Appoints Gary Riley as Vice President Nonclinical Development & Applied Biology
Emisphere Technologies, Inc. Appoints Gary Riley as Vice President Nonclinical Development & Applied Biology
HSMN NewsFeed - 23 Oct 2007
FDA Issues Approvable Letter for Stavzor(TM) Delayed Release Valproic Acid Capsules
FDA Issues Approvable Letter for Stavzor(TM) Delayed Release Valproic Acid Capsules
HSMN NewsFeed - 18 Oct 2007
Duska Therapeutics Appoints Shepard Goldberg and Steven Dinh as Board Directors
Duska Therapeutics Appoints Shepard Goldberg and Steven Dinh as Board Directors
HSMN NewsFeed - 10 Oct 2007
NuPathe Inc. Names Jerry McLaughlin as Vice President of Commercial Operations
NuPathe Inc. Names Jerry McLaughlin as Vice President of Commercial Operations
HSMN NewsFeed - 3 Oct 2007
Postoperative Pain is an Under Appreciated, Under Treated Problem in the United States
Postoperative Pain is an Under Appreciated, Under Treated Problem in the United States
HSMN NewsFeed - 1 Oct 2007
Valeant Pharmaceuticals to Partner with ASCEND Therapeutics to Promote Migranal(R) to OB/GYNs
Valeant Pharmaceuticals to Partner with ASCEND Therapeutics to Promote Migranal(R) to OB/GYNs
HSMN NewsFeed - 26 Sep 2007
Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
HSMN NewsFeed - 25 Sep 2007
Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
HSMN NewsFeed - 13 Sep 2007
Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
HSMN NewsFeed - 11 Sep 2007
Crospon Licenses HP Technology to Create Industry-First Skin Patch for ''Smart'' Drug Delivery
Crospon Licenses HP Technology to Create Industry-First Skin Patch for ''Smart'' Drug Delivery
HSMN NewsFeed - 5 Sep 2007
BioSante Pharmaceuticals Names Joy A. Thomas Vice President of Corporate Development
BioSante Pharmaceuticals Names Joy A. Thomas Vice President of Corporate Development
HSMN NewsFeed - 4 Sep 2007
Transdermal Patch Growth Relying on Improved Designs, Enhanced Manufacturing Methods
Transdermal Patch Growth Relying on Improved Designs, Enhanced Manufacturing Methods
HSMN NewsFeed - 23 Aug 2007
Antares Announces Initiation of Pivotal Trial of ANTUROL(TM) for the Treatment of Overactive Bladder
Antares Announces Initiation of Pivotal Trial of ANTUROL(TM) for the Treatment of Overactive Bladder
HSMN NewsFeed - 22 Aug 2007
Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
HSMN NewsFeed - 8 Aug 2007
IOMED Receives Shareholder Approval of Merger Agreement with ReAble Therapeutics
IOMED Receives Shareholder Approval of Merger Agreement with ReAble Therapeutics
HSMN NewsFeed - 2 Aug 2007
Vyteris Announces Appointment of Anthony J. Cherichella as Chief Financial Officer
Vyteris Announces Appointment of Anthony J. Cherichella as Chief Financial Officer
HSMN NewsFeed - 1 Aug 2007
Genta and Emisphere Technologies File IND with FDA for Oral Drug to Treat Bone Disease
Genta and Emisphere Technologies File IND with FDA for Oral Drug to Treat Bone Disease
HSMN NewsFeed - 1 Aug 2007
Orexo Establishes Sales Force in Nordic Markets, by Entering into a Joint Venture with ProStrakan
Orexo Establishes Sales Force in Nordic Markets, by Entering into a Joint Venture with ProStrakan
HSMN NewsFeed - 30 Jul 2007
KV Pharmaceutical Announces U.S. Food and Drug Administration Approval of EvaMist(TM)
KV Pharmaceutical Announces U.S. Food and Drug Administration Approval of EvaMist(TM)
HSMN NewsFeed - 25 Jul 2007
Antares Reaches Agreement with FDA on Special Protocol Assessment for Pivotal Trial of Anturol(TM)
Antares Reaches Agreement with FDA on Special Protocol Assessment for Pivotal Trial of Anturol(TM)
HSMN NewsFeed - 19 Jul 2007
Antares Announces Worldwide Development and License Agreement with Jazz Pharmaceuticals
Antares Announces Worldwide Development and License Agreement with Jazz Pharmaceuticals
HSMN NewsFeed - 10 Jul 2007
Noven to Acquire JDS Pharmaceuticals, Expanding Business Model & Broadening Product Pipeline
Noven to Acquire JDS Pharmaceuticals, Expanding Business Model & Broadening Product Pipeline
HSMN NewsFeed - 27 Jun 2007
DURECT Announces the Initiation of Sufentanil Patch Phase II Study by Endo Pharmaceuticals
DURECT Announces the Initiation of Sufentanil Patch Phase II Study by Endo Pharmaceuticals
HSMN NewsFeed - 21 Jun 2007
LAB International licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica NV for Europe
LAB International licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica NV for Europe
HSMN NewsFeed - 12 Jun 2007
BioSante Pharmaceuticals Announces Reinitiation of Product Development With Teva
BioSante Pharmaceuticals Announces Reinitiation of Product Development With Teva
HSMN NewsFeed - 18 May 2007
Ogenix Announces Intent to License EpiFLO SD(R) Technology to Minerva Healthcare
Ogenix Announces Intent to License EpiFLO SD(R) Technology to Minerva Healthcare
HSMN NewsFeed - 16 May 2007
KV Pharmaceutical Company Completes Acquisition of U.S. Rights to EvaMist(TM)
KV Pharmaceutical Company Completes Acquisition of U.S. Rights to EvaMist(TM)
HSMN NewsFeed - 9 May 2007
Data Show Low Incidence of Breakthrough Bleeding With ORTHO TRI-CYCLEN(R) LO In a Broad Range of Women
Data Show Low Incidence of Breakthrough Bleeding With ORTHO TRI-CYCLEN(R) LO In a Broad Range of Women
HSMN NewsFeed - 7 May 2007
BioSante Pharmaceuticals Signs Oral Contraceptive License with Pantarhei Bioscience
BioSante Pharmaceuticals Signs Oral Contraceptive License with Pantarhei Bioscience
HSMN NewsFeed - 3 May 2007
Successful Human Clinical Trial of Chrono Therapeutic's Drug/Device Combination Product - ChronoDose(TM)
Successful Human Clinical Trial of Chrono Therapeutic's Drug/Device Combination Product - ChronoDose(TM)
HSMN NewsFeed - 19 Apr 2007
Antares Pharma Announces Positive Results from Application Site Study for ANTUROL(R)
Antares Pharma Announces Positive Results from Application Site Study for ANTUROL(R)
HSMN NewsFeed - 16 Apr 2007
SCHWARZ PHARMA Announces Publication of Rotigotine Data for Advanced Parkinson's Disease in Neurology
SCHWARZ PHARMA Announces Publication of Rotigotine Data for Advanced Parkinson's Disease in Neurology
HSMN NewsFeed - 26 Mar 2007
USDA Grants Conditional Approval for First Therapeutic Vaccine to Treat Cancer
USDA Grants Conditional Approval for First Therapeutic Vaccine to Treat Cancer
HSMN NewsFeed - 19 Mar 2007
New Phase IV Clinical Study Indicates LidoSite(R) Provides Rheumatology Patients Superior Pain Relief
New Phase IV Clinical Study Indicates LidoSite(R) Provides Rheumatology Patients Superior Pain Relief
HSMN NewsFeed - 7 Mar 2007
Nuvo announces further update on discussions with the FDA related to review of Pennsaid
Nuvo announces further update on discussions with the FDA related to review of Pennsaid
HSMN NewsFeed - 31 Jan 2007
NexMed Announces Patient Dosing in Phase 3 Program for Anti-Fungal Product
NexMed Announces Patient Dosing in Phase 3 Program for Anti-Fungal Product
HSMN NewsFeed - 31 Jan 2007
Mylan Announces Final FDA Approval for Its 12 mcg/hr Fentanyl Transdermal System
Mylan Announces Final FDA Approval for Its 12 mcg/hr Fentanyl Transdermal System
HSMN NewsFeed - 9 Jan 2007
Cephalon Announces Positive Results from Two Phase 3 Clinical Trials of FENTORA(TM) in Breakthrough Pain
Cephalon Announces Positive Results from Two Phase 3 Clinical Trials of FENTORA(TM) in Breakthrough Pain
HSMN NewsFeed - 8 Jan 2007
Cephalon Announces Positive Results from Two Phase 3 Clinical Trials of FENTORA(TM) in Breakthrough Pain
Cephalon Announces Positive Results from Two Phase 3 Clinical Trials of FENTORA(TM) in Breakthrough Pain
HSMN NewsFeed - 27 Dec 2006
Sontra Medical Corporation Announces Plan to Cease Operations and to Voluntarily Delist From Nasdaq
Sontra Medical Corporation Announces Plan to Cease Operations and to Voluntarily Delist From Nasdaq
HSMN NewsFeed - 22 Dec 2006
Healthcare Marketing Expert Joins Valeritas as Vice President of Marketing & Marketing Operations
Healthcare Marketing Expert Joins Valeritas as Vice President of Marketing & Marketing Operations
HSMN NewsFeed - 19 Dec 2006
Bradley Pharmaceuticals Announces FDA Approval of Elestrin(TM) (estradiol gel 0.06%)
Bradley Pharmaceuticals Announces FDA Approval of Elestrin(TM) (estradiol gel 0.06%)
HSMN NewsFeed - 8 Nov 2006
BioSante Pharmaceuticals Signs Bio-E-Gel(R) Marketing Agreement With Bradley Pharmaceuticals, Inc.
BioSante Pharmaceuticals Signs Bio-E-Gel(R) Marketing Agreement With Bradley Pharmaceuticals, Inc.
HSMN NewsFeed - 26 Oct 2006
DAYTRANA(TM) (methylphenidate transdermal system) Provides Individualized Symptom Management
DAYTRANA(TM) (methylphenidate transdermal system) Provides Individualized Symptom Management
HSMN NewsFeed - 12 Oct 2006
BioSante Pharmaceuticals Presents Bio-E-Gel(R) Woman-to-Partner Transfer Study at Menopause Society Meeting
BioSante Pharmaceuticals Presents Bio-E-Gel(R) Woman-to-Partner Transfer Study at Menopause Society Meeting
HSMN NewsFeed - 4 Oct 2006
Antares Pharma to Supply Teva with Innovative Needle-Free Injection System
Antares Pharma to Supply Teva with Innovative Needle-Free Injection System
HSMN NewsFeed - 20 Sep 2006
ProEthic Pharmaceuticals Promotes Roger Graben to Vice President, Business Development
ProEthic Pharmaceuticals Promotes Roger Graben to Vice President, Business Development
HSMN NewsFeed - 19 Sep 2006
Cancer Patients Show Reduced Pain and Lower Analgesic Consumption Following Treatment with QUADRAMET(R)
Cancer Patients Show Reduced Pain and Lower Analgesic Consumption Following Treatment with QUADRAMET(R)
HSMN NewsFeed - 18 Jul 2006
Antares Pharma Announces Licensing Agreement with Teva for Novel Injector Device
Antares Pharma Announces Licensing Agreement with Teva for Novel Injector Device
HSMN NewsFeed - 29 Jun 2006
Noven Confirms Availability of Daytrana(TM) Methylphenidate Transdermal System
Noven Confirms Availability of Daytrana(TM) Methylphenidate Transdermal System
HSMN NewsFeed - 26 Jun 2006
NexMed Announces Termination of Alprox-TD Agreement With Schering AG and Provides Operational Update
NexMed Announces Termination of Alprox-TD Agreement With Schering AG and Provides Operational Update
HSMN NewsFeed - 25 May 2006
Agile Therapeutics Closes $12 Million Financing for Development of a Low Estrogen Dose Contraceptive Patch
Agile Therapeutics Closes $12 Million Financing for Development of a Low Estrogen Dose Contraceptive Patch
HSMN NewsFeed - 25 May 2006
Significant ADHD Symptom Control With Shorter DAYTRANA(TM) (methylphenidate transdermal system) Wear Time
Significant ADHD Symptom Control With Shorter DAYTRANA(TM) (methylphenidate transdermal system) Wear Time
HSMN NewsFeed - 23 May 2006
ALZA Corporation Receives FDA Approval for IONSYS(TM) (Fentanyl Iontophoretic Transdermal System)
ALZA Corporation Receives FDA Approval for IONSYS(TM) (Fentanyl Iontophoretic Transdermal System)
HSMN NewsFeed - 9 May 2006
Sontra Medical Introduces Generation 2.0 SonoPrep(R) Skin Permeation Device
Sontra Medical Introduces Generation 2.0 SonoPrep(R) Skin Permeation Device
HSMN NewsFeed - 4 May 2006
GlaxoSmithKline and Adolor Present Positive Results from a Clinical Study of Alvimopan (Entereg(R))
GlaxoSmithKline and Adolor Present Positive Results from a Clinical Study of Alvimopan (Entereg(R))
Additional items found! 279
Members Archive contains
279 additional stories matching:
Transdermal
(Password required)
Transdermal
(Password required)